Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-30

Clinical Trial Update: Retrospective Study on the Role of SCFA Modulation in Multiple Sclerosis

View source ↗

Summary

Clinical trial update describing a retrospective study investigating the role of short-chain fatty acid modulation in multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Prof. Massimo Filippi | Conditions: Multiple Sclerosis | Status: ACTIVE_NOT_RECRUITING